Cardinal Health’s global coverage has surged, with 37 mentions in recent media analysis, marking a major expansion in its international presence.
Cardinal Health Surges In Global Coverage
Browsing Category
Healthcare operations
44 posts
Gum Line Photography: Daily Monitoring For Optimal Dental Health
A new approach uses daily phone photos of the gum line to track inflammation and improve preventive dental care, currently in testing with a small patient group.
How To Streamline Spiritual Support Operations In Healthcare Settings
A new software approach aims to digitize hospital chaplaincy workflows, improving efficiency and documentation in spiritual care.
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
Ascentage Pharma appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer, strengthening its leadership team.
Anonymous daily check-ins for 12-step sponsors
A new prototype allows AA and NA sponsors to conduct anonymous daily check-ins with sponsees via pseudonymous threads, aiming to improve support while maintaining anonymity.
THE STORK FOUNDATION FOR INFERTILITY OPENS 2026 GRANT APPLICATIONS TO EASE FINANCIAL BURDEN OF IVF TREATMENTS
The Stork Foundation for Infertility has announced the opening of its 2026 grant applications to help reduce the financial burden of IVF treatments.
Clearmind Medicine Successfully Completes Part A Of Its FDA Regulated Phase I/II Trial
Clearmind Medicine has successfully completed Part A of its FDA-regulated Phase I/II trial, advancing its research into novel therapies.
Advances In CRISPR Tech Boost Consumer Safety By Shredding Resistant Cancer Cells
New CRISPR technology has demonstrated the ability to selectively destroy resistant cancer cells, including ‘undruggable’ types, marking a significant step in cancer therapy.
TransMedics To Report Second Quarter 2026 Financial Results On August 4, 2026
TransMedics will release its second quarter 2026 financial results on August 4, 2026, with analysts and investors awaiting the report’s details on company performance.
MaxCyte® Announces Multi-Platform Technology License Partnership With Genentech® To Advance Cell Therapy Development
MaxCyte announces a multi-platform technology licensing partnership with Genentech to accelerate cell therapy development, expanding collaborative capabilities.
